Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Pfizer and Innovent Sign $10.5B Deal for New Cancer Drug Development
Pfizer and Innovent Biologics strike a $10.5 billion licensing deal to co-develop 12 early-stage cancer medications, including antibody-drug conjugates.
GSK’s Nucala Secures NICE Endorsement for Uncontrolled COPD Treatments
The UK's NICE recommends GSK's Nucala (mepolizumab) for patients with uncontrolled COPD, expanding its clinical use alongside standard of care therapies.
FDA Grants Fast Track Designation to Elunetirom for Bipolar Depression
Autobahn Therapeutics receives FDA Fast Track status for elunetirom, a novel CNS-TR agonist aimed at treating adjunctive bipolar depression and MDD.
AI in Clinical Trials: Trust and Regulatory Concerns Remain Top Barriers
A Pistoia Alliance poll reveals that trust and regulatory uncertainty are the biggest barriers to adopting artificial intelligence in clinical trials.
Atossa Presents Preclinical Breast Cancer Drug Data at ASCO 2026 Meeting
Atossa Therapeutics highlights promising preclinical data for (Z)-endoxifen in ESR1-mutant breast cancer models at ASCO 2026, alongside clinical updates.
Vitamin B12-Like Drug NO-Cbl Shows Promise in Preclinical Glioma Studies
A new preclinical study reveals NO-Cbl, a Vitamin B12-mimicking therapy, successfully targets glioblastoma cells and acts synergistically with chemotherapy.
Rectify Unveils Preclinical Data on RTY-406 for Rare Liver Disease Care
At the EASL 2026 Congress, Rectify Pharmaceuticals shared promising preclinical data for RTY-406, a novel treatment for Primary Sclerosing Cholangitis.
Industry Confidence in FDA Hinges on Stable CBER and CDER Leadership Roles
Experts warn that FDA's significant leadership turnover and reliance on acting directors at CDER and CBER may challenge regulatory predictability and trust.
Unveils Next-Gen AI Imaging Solution for Clinical Trials at ASCO
Medidata announces a new AI-powered imaging solution at ASCO 2026, offering unprecedented speed, >97% accuracy, and QC to accelerate clinical trials.
FDA Approves Datroway as First-Line Therapy for Triple Negative Cancer
AstraZeneca and Daiichi's Datroway receives FDA approval as a first-line targeted therapy for triple-negative breast cancer, outperforming chemotherapy.
AI-Guided Drug Search Identifies Folic Acid for Diabetic Wound Healing
NUS researchers combined AI and molecular simulations to identify folic acid as a promising treatment for diabetic wound healing, saving significant time.
FDA Grants Priority Review: Finerenone for CKD in Type 1 Diabetes Care
The FDA has granted priority review to Bayer’s finerenone for chronic kidney disease in adults with type 1 diabetes based on positive FINE-ONE trial data.
5
6
7
8
9
10
11
12
13
